Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of BMS-986142 on PK of Methotrexate and Probe Substrates
NCT02456844Phase 1Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of BMS-986142 in rheumatoid arthritis (RA) (2 arms), sponsored by Bristol Myers Squibb. Primary endpoints: Maximum observed plasma concentration, Area under the plasma concentration-time curve from time zero to the time of last quantifiable concentration and 1 more. Started May 2015; status: completed.
02
Drugs
BMS-986142
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02456844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02456844.